Clinical trials · Richmond, VA
Relapsed/Refractory Multiple Myeloma clinical trials in Richmond
We’re tracking 4 recruiting relapsed/refractory multiple myeloma studies with a site in or near Richmond — including Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Richmond
- NCT06158841RecruitingPhase 3
Etentamig vs standard therapy for relapsed myeloma
This trial tests a new IV treatment called etentamig compared to standard therapies for people with multiple myeloma that has come back or stopped responding. It may be an option if you've already tried at least two different treatments, including common drug classes.
Richmond, VirginiaAges 18 years+ - NCT05722418RecruitingPhase 1
CRISPR-edited CAR-T for harder-to-treat myeloma
This Phase 1 study tests a lab-made immune cell therapy (CAR-T) made from a donor, with a CRISPR edit, for multiple myeloma that has come back or not responded to treatment. It aims to find the safest way to give the treatment and see how well it can control the cancer.
Richmond, VirginiaAges 18 years+ - NCT05332054Enrolling by invitation
Long-term follow-up after prior Caribou treatment
This study checks your health over time after you previously took a Caribou medicine (or got it through a special access program). It helps researchers learn what happens in the longer run after the treatment.
Richmond, VirginiaAges 18 years+ - NCT05862012RecruitingPhase 1
Test drug ISB 2001 in multiple myeloma patients who relapsed
This Phase 1 study tests ISB 2001, a new investigational treatment, in people with multiple myeloma that has come back or not responded to prior treatment. It mainly focuses on safety and whether the drug can be given effectively.
Richmond, VirginiaAges 18 years+
Hear when a new Relapsed/Refractory Multiple Myeloma trial opens near Richmond, VA
We’ll email you when one opens near Richmond, VA — at most once a week, no account needed, unsubscribe anytime.
Relapsed/Refractory Multiple Myeloma trials in other cities
Where these studies are running near Richmond
Institutions with a site for the recruiting relapsed/refractory multiple myeloma studies listed above.
- Virginia Commonwealth University · 4 studies
What taking part in a relapsed/refractory multiple myeloma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting relapsed/refractory multiple myeloma studies in Virginia.
Common questions
- Are there relapsed/refractory multiple myeloma clinical trials near Richmond?
- Yes. We're currently tracking 4 recruiting relapsed/refractory multiple myeloma studies with a site near Richmond, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a relapsed/refractory multiple myeloma study near Richmond?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Richmond to take part?
- Not necessarily. These studies have a site near Richmond, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a relapsed/refractory multiple myeloma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New relapsed/refractory multiple myeloma studies open near Richmond regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.